Effects of CYP2D6 polymorphisms on neuroleptic malignant syndrome.
European journal of clinical pharmacology 2007 Nov 63 (11): 991-6.
Kato Daiji, Kawanishi Chiaki, Kishida Ikuko, Furuno Taku, Suzuki Kyoko, Onishi Hideki, Hirayasu Yosh
Lack of association in Japanese patients between neuroleptic malignant syndrome and a debrisoquine 4-hydroxylase genotype with low enzyme activity.
Psychiatric genetics 2000 Sep 10 (3): 145-7.
Kawanishi C, Furuno T, Onishi H, Sugiyama N, Suzuki K, Matsumura T, Ishigami T, Kosaka